Organ Health Publications
Read Article
Resource Library
Natera Resource Hub - your source for articles and videos.
-
-
ctDNA-based molecular residual disease and survival in resectable colorectal cancer
Nakamura, et al. Nature Medicine 2024
Read Publication
-
Prospera Kidney MD Brochure
Read More
-
Renasight Patient Brochure
Discover how Renasight can provide valuable information about your kidney health.
Read More
-
Have a question or comment?
Contact Us -
Why Prospera Surveillance Brochure
The Prospera non-invasive blood test can comprehensively identify all types of active rejection with great precision.
Read More
-
Elevations of dd-cfDNA before bpAR ProActive Study Publication with Supplement April 2024
Bromberg, et al. Transplantation 2024
Read Publication
-
Renasight Provider Brochure
Learn about Renasight genetic testing and how it can provide valuable information for patient management of kidney disease.
Read More
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about: • His dd-cfDNA “surveillance journey” and protocol development.
Watch Video
-
How Dr. Yasir Qazi embraced cell-free DNA surveillance, an unaffected approach due to the recent CMS update - Audio Only
Hear from our ProActive Study Investigator In this episode of our Inside the ProActive Study Podcast, Dr. Yasir Qazi talks to us about his dd-cfDNA “surveillance journey” and protocol development.
Listen Now
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance protoc
Watch Video
-
How Dr. Matthew Cooper leverages dd-cfDNA to replace protocol biopsies for surveillance, in-line with ASTS recommended use
In this episode of our Inside the ProActive Study Podcast, Dr. Matthew Cooper shares his insights on: • Utilizing cfDNA alongside DSA and biopsies before implementing his dd-cfDNA surveillance...
Listen Now
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Watch Video
-
How Dr. Millie Samaniego bridged the gap between study use and routine care by extending protocolized use
In this episode of our Inside the ProActive Study Podcast, Dr. Millie Samaniego-Picota tells us about: • Her experience expanding the ProActive Study Protocol schedule to all her patients • How her
Listen Now
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care
Watch Video
-
Inside the ProActive Study- How Dr Sanjeev Akkina and Dr. Jessica Coleman approach the continuity of transplant recipient care podcast
Listen Now
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Watch Video
-
How Dr. Anand championed a surveillance protocol informed by his deep experience and research
Listen Now
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Watch Video
-
How Dr. Batarse advocates for his patients upon early recognition of subtle rejection using cfDNA
Listen Now
-
Meet Jon, Muscle-Invasive Bladder Cancer (MIBC) Survivor and Signatera Patient
Read Article
-
Alteration of the Tumor Microenvironment With Intratumoral Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer A Nonrandomized Clinic
Han, H.S. et al; JAMA Oncology 2025
Read Publication
-
Adjuvant endocrine therapy with cyclindependent kinase 4/6 inhibitor, ribociclib, for localized hormone receptor-positive/ HER2– breast canc
Spring L. M. et al; npj Breast Cancer 2025
Read Publication
-
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasi
Foldi J; JCO Precision Oncology 2025
Read Publication
-
Peri-operative atezolizumab in early-stage triple-negative breast cancer: final results and ctDNA analyses from the randomized phase 3 IMpas
Mittendorf E. A. et al; Nature Medicine 2025
Read Publication
-
Have a question or comment?
Contact Us -
Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study
Reason E. H. et al; Ann Surg Oncol 2025
Read Publication
-
Detection and Monitoring of Breast Cancer Local Recurrence Via Circulating Tumor DNA Minimal Residual Disease Assay
Prasath V, et al; JCO Precision Oncology 2025
Read Publication
-
Circulating tumor DNA refines risk stratification of neoadjuvant therapyresistant breast tumors
Magbanua M. J. et al; Nature Communications 2025
Read Publication
-
Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series
Wong K, et al; Ther Adv Med Oncol 2025
Read Publication
-
Dr. Barry Rosen - Nothing Else Compares
Dr. Barry Rosen answers the question to "Why did you start incorporating MRD in your practice?" Dr. Rosen discusses why he incorporated MRD testing into their patient care algorithm. They note that tr
Watch Video
-
Meet Amanda, Colorectal Cancer Survivor and Signatera Patient
Read Article
-
Accelerating Kidney Disease Clinical Trials: Merging real-world data with patient insights
Watch Video
-
Donor-Derived Cell-Free DNA in Pancreas-Kidney, Heart-Kidney, and Liver-Kidney Multiorgan Transplant Recipients (MOTR)
Gupta, et al. Transplant International. 2026
Read Publication
-
PARPi Study Publication Summary
Read More
-
Validation of a methylation-based, tissue-free MRD assay in colorectal cancer patients from the GALAXY study
Nakamura Y. Reiter J.G. Natarajan P. et al. npj Precis. Onc. 2026
Read Publication
-
Signatera Publications
Read Article
-
Genetic cohorting and therapeutic response in CKD: Real-world insights from RenasightIQ
Watch Video
-
Meet Amanda, Colorectal Cancer Survivor and Signatera Patient
Amanda shares her powerful and unexpected journey. A routine genetic screening during her pregnancy led to a Stage IV colon cancer diagnosis. She underwent chemo while pregnant, had surgery after her
Watch Video
-
Surveillance Donor-derived Cell-free DNA Allows for the Safe Reduction in Protocol Transbronchial Biopsies After Lung Transplantation
Kashika Goyal, et al. Transplantation Direct. 2026
Read Publication
-
Redefining heart transplant care: How donor-derived cell-free DNA is transforming rejection surveillance
This webinar highlights the DEFINE-HT study initial results and the two-threshold algorithm: fraction + DQS.
Watch Video
-
Loading More...
